| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Other Lab Tests Articles
Not Just Cholesterol-Lowing Benefits
A South Carolina study indicates that simvastatin (Zocor), an oral “statin” lipid-lowering drug is a potentially beneficial treatment for the inflammatory reaction associated with atherosclerosis.
Twenty-six patients with type 2 diabetes participated in the study. They were started on a lipid-lowering diet and encouraged to exercise in addition to receiving Zocor treatment that was adjusted until LDL cholesterol levels reached 100 mg/dl or lower.
A1C levels remained constant throughout the study. There was a highly significant reduction in blood levels of immune complexes containing modified lipoproteins after three to six months of treatment with Zocor.
Levels returned to baseline after Zocor use was discontinued.
Researchers note this may represent an additional mechanism for the reduced incidence of cardiovascular events in patients treated with Zocor.
—Diabetes Care, April 2004
Categories: Other Lab Tests, Type 2 Issues
Jun 1, 2004 -
Email to a Friend
Send a link to this page to your friends and colleagues.